What is Chemours's cumulative cost basis?

Chemours (CC) reported cumulative cost basis of $9.93B in Q1 2026.

How has Chemours's cumulative cost basis changed year-over-year?

Chemours's cumulative cost basis increased by 3.1% year-over-year, from $9.63B to $9.93B.

What is the long-term trend for Chemours's cumulative cost basis?

Over 5 years (2020 to 2025), Chemours's cumulative cost basis has grown at a 0.7% compound annual growth rate (CAGR), from $9.58B to $9.92B.

Chemours CC Cumulative Cost Basis

Cumulative Cost Basis at other companies

Eastman ChemicalEMN

——

Element SolutionsESI

——

Cabot CorporationCBT

——

AvientAVNT

——

MaterionMTRN

——

WestlakeWLK

——

Other financials

Income statement

See full

Revenue$1.4B+1.0%

Gross profit$212.0M-10.2%

Net income-$29.0M-480%

EPS (diluted)-$0.19-533%

Balance sheet

See full

Cash & equivalents$563.0M+21.3%

Total debt$4.4B0.0%

Total equity$215.0M-62.0%

Total assets$7.3B-1.5%

Cash flow

See full

Operating cash flow-$44.0M+60.7%

CapEx$49.0M-41.7%

Free cash flow-$93.0M+52.6%

Valuation

See full

Market cap$3B+63.6%

Profitability

See full

Gross margin15.1%-3.8pp

Net margin-7%-7.3pp

FCF margin5.1%-1.7pp

Returns & leverage

See full

Return on equity-105%-107pp

Debt / equity20.6×+12.8×

Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemours's cumulative cost basis?: Chemours (CC) reported cumulative cost basis of $9.93B in Q1 2026.
How has Chemours's cumulative cost basis changed year-over-year?: Chemours's cumulative cost basis increased by 3.1% year-over-year, from $9.63B to $9.93B.
What is the long-term trend for Chemours's cumulative cost basis?: Over 5 years (2020 to 2025), Chemours's cumulative cost basis has grown at a 0.7% compound annual growth rate (CAGR), from $9.58B to $9.92B.